Sb. Pillai et al., HEPARIN-BINDING EGF-LIKE GROWTH-FACTOR IS CYTOPROTECTIVE FOR INTESTINAL EPITHELIAL-CELLS EXPOSED TO HYPOXIA, Journal of pediatric surgery, 33(7), 1998, pp. 973-978
Background: During recovery from intestinal ischemic injury, there is
rapid growth of intestinal epithelia with regeneration of damaged vill
i, This study examines the effects of heparin-binding EGF-like growth
factor (HB-EGF) on the recovery of intestinal epithelial cells exposed
to hypoxia. Methods: The cytoprotective effects of HB-EGF were analyz
ed by placing IEC-18 cells in an anaerobic chamber with various timed
HB-EGF treatments (prehypoxia, posthypoxia, pre- and posthypoxia, and
no treatment). After 10 hours of hypoxia, lactate dehydrogenase (LDH)
release, actin-filament (structural) integrity, adenosine triphosphate
(ATP) levels, and posthypoxia proliferative activity were evaluated.
Results: LDH analysis showed that HB-EGF exerted a cytoprotective effe
ct during hypoxia. Pretreated cells had a significantly lower death ra
te during recovery (7.48%) compared with cells with no HB-EGF treatmen
t (22.19%, P < .009). Confocal microscopic structural analysis of post
hypoxia cells showed that F-actin structure was maintained in treated
cells, whereas nontreated cells showed increased structural deteriorat
ion. ATP levels were significantly higher in the HB-EGF-treated cells
compared with nontreated cells at 48 hours (P < .05). Finally, HB-EGF-
treated cells had a significantly improved proliferative ability compa
red with nontreated cells during recovery from hypoxia (P <.05). Concl
usions: HB-EGF is a mitogenic growth factor for intestinal epithelial
cells. Moreover, HB-EGF appears to protect intestinal epithelial cells
from hypoxia, in part via maintenance of cytoskeletal structure and A
TP stores. Finally, HB-EGF-treated cells also appear to have better pr
oliferative abilities during recovery from hypoxia. J Pediatr Surg 33:
973-979. Copyright (C) 1998 by W.B. Saunders Company.